1
|
Ambrosino F, La Verde G, Colucci M, Fanti V, Barrale D, Caciolli A, Hemmer S, De Giorgi ML, Ventura A, Immè J, Pagano A, Budinich M, Vascotto M, Montalbano V, Capua M, Tucci R, Chiosso M, Visca L, Groppi F, Pugliese M. RadioLab project: knowledge of radon gas in Italy. Sci Rep 2024; 14:1224. [PMID: 38216583 PMCID: PMC10786923 DOI: 10.1038/s41598-023-45809-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Accepted: 10/24/2023] [Indexed: 01/14/2024] Open
Abstract
RadioLab is an Italian project, addressed to school-age people, and designed for the dissemination of scientific culture on the theme of environmental radioactivity, with particular regards to the importance of knowledge of radon gas exposure. The project is a nationwide initiative promoted by the National Institute of Nuclear Physics- INFN. First tool used by the project, and of immediate impact to assess the public awareness on radon, is the administration of the survey "do you know the radon gas?". In the survey, together with the knowledge of radon and of its sources, information on personal, cultural and territorial details regarding the interviewees are also taken. Reasonably, the survey invests not only young people, but also their relatives, school workers and, gradually, the public. The survey is administrated during exhibitions or outreach events devoted to schools, but also open to the public. The survey is in dual form: printed and online. The online mode clearly leads RadioLab project even outside the school environment. Based on the results of the survey, several statistical analyses have been performed and many conclusions are drawn about the knowledge of the population on the radon risk. The RadioLab benefit and the requirement to carry on the project goals, spreading awareness of environmental radioactivity from radon, emerge. The dataset involves all twenty Italian regions and consists of 28,612 entries covering the 5-year period 2018-2022.
Collapse
Affiliation(s)
- F Ambrosino
- INFN-National Institute of Nuclear Physics, Napoli Section, Naples, Italy.
- Department of Physics "Ettore Pancini", University of Napoli Federico II, Naples, Italy.
| | - G La Verde
- INFN-National Institute of Nuclear Physics, Napoli Section, Naples, Italy
- Department of Physics "Ettore Pancini", University of Napoli Federico II, Naples, Italy
| | - M Colucci
- INFN-National Institute of Nuclear Physics, Milano Section, Milan, Italy
- Department of Physics Aldo Pontremoli, University of Milano, Milan, Italy
| | - V Fanti
- INFN-National Institute of Nuclear Physics, Cagliari Section, Cagliari, Italy
- Department of Physics, University of Cagliari, Cagliari, Italy
| | - D Barrale
- INFN-National Institute of Nuclear Physics, Cagliari Section, Cagliari, Italy
- Department of Physics, University of Cagliari, Cagliari, Italy
| | - A Caciolli
- INFN-National Institute of Nuclear Physics, Padova Section, Padua, Italy
- Department of Physics and Astronomy, University of Padova, Padua, Italy
| | - S Hemmer
- INFN-National Institute of Nuclear Physics, Padova Section, Padua, Italy
| | - M L De Giorgi
- INFN-National Institute of Nuclear Physics, Lecce Section, Lecce, Italy
| | - A Ventura
- INFN-National Institute of Nuclear Physics, Lecce Section, Lecce, Italy
| | - J Immè
- INFN-National Institute of Nuclear Physics, Catania Section, Catania, Italy
| | - A Pagano
- INFN-National Institute of Nuclear Physics, Catania Section, Catania, Italy
| | - M Budinich
- INFN-National Institute of Nuclear Physics, Trieste Section, Trieste, Italy
| | - M Vascotto
- INFN-National Institute of Nuclear Physics, Trieste Section, Trieste, Italy
| | - V Montalbano
- INFN-National Institute of Nuclear Physics, Pisa Section, Pisa, Italy
- Department of Physical Sciences, Earth and Environment, University of Siena, Siena, Italy
| | - M Capua
- INFN-National Institute of Nuclear Physics, Cosenza Section, Cosenza, Italy
- Department of Physics, University of Calabria, Calabria, Italy
| | - R Tucci
- INFN-National Institute of Nuclear Physics, Cosenza Section, Cosenza, Italy
| | - M Chiosso
- INFN-National Institute of Nuclear Physics, Torino Section, Turin, Italy
- Department of Physics, University of Torino, Turin, Italy
| | - L Visca
- INFN-National Institute of Nuclear Physics, Torino Section, Turin, Italy
- Department of Physics, University of Torino, Turin, Italy
| | - F Groppi
- INFN-National Institute of Nuclear Physics, Milano Section, Milan, Italy
- Department of Physics Aldo Pontremoli, University of Milano, Milan, Italy
| | - M Pugliese
- INFN-National Institute of Nuclear Physics, Napoli Section, Naples, Italy
- Department of Physics "Ettore Pancini", University of Napoli Federico II, Naples, Italy
| |
Collapse
|
2
|
Omar AE, Sakr MAH, Taalab SA, Bakhit ABA, Pugliese M, La Verde G, Hanfi MY. Geotechnical and environmental radioactivity investigations at Al Sādis Min Uktōber city, Cairo municipality (Egypt), for the high-speed railway construction. Appl Radiat Isot 2023; 193:110664. [PMID: 36669267 DOI: 10.1016/j.apradiso.2023.110664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2022] [Accepted: 01/11/2023] [Indexed: 01/15/2023]
Abstract
The present study aims to evaluate the possibility of constructing a new high-speed railway (HSR) at Al Sādis Min Uktōber city, Cairo (Egypt): geotechnical and environmental radiological hazards are estimated from several collected soil and water samples. A variety of laboratory geotechnical tests such as grain size, free swelling test, liquid and plastic limits, chemical analysis and uniaxial compression strength are applied to sixty-one drill holes. A geotechnical examination of the coarse-grained soil at the foundation level classified it as poorly graded soil. The results of the investigation of fine-grained soil at the foundation level shown that the liquid limit ranges from 22% to 55%, the plastic limit ranges from 12% to 28%, the plasticity index varies from 11% to 33%, free swelling varies from 51% to 71%. Mechanically, the uniaxial compressive strength values on rock samples range from 6.96 MPa to 142.39 MPa. The radioactive study is performed to detect the 226Ra, 232Th, and 40 K activity concentrations of the soil samples: their mean values are 34 ± 10 Bq·kg-1, 14 ± 5 Bq·kg-1 and 552 ± 20 Bq·kg-1, respectively. The values of radiological hazard indexes are not exceeded the permissible limits: e.g. the mean value of absorbed dose rate is 47 ± 6 nGy h-1; the annual gonadal dose equivalent is 0.3 ± 0.04 mSv·y-1; the lifetime cancer risk is 02 ± 0.2·10-3. Thus, the soil in the studied railway area is safe to use in building materials and infrastructure applications: the radiological hazards and the geotechnical studies confirmed the studied area is suitable to construct a new community having a HSR. According to the SWOT-PEST and environmental impact analyses, the construction of the HSR meets the criteria of the Kyoto Protocol, the EU Climate and Energy policy, and other international treaties.
Collapse
Affiliation(s)
- Ali E Omar
- Nuclear Materials Authority, El Maadi, Cairo, P.O. Box 530, Egypt
| | - Mohamed A H Sakr
- Department of Geology, Faculty of Science, Al-Azhar University, Cairo, P.O. Box, 11884, Egypt.
| | - Sherif A Taalab
- Department of Geology, Faculty of Science, Al-Azhar University, Cairo, P.O. Box, 11884, Egypt
| | | | - M Pugliese
- University of Naples Federico II, Department of Physics "E. Pancini", Via Cinthia 21, 80126, Napoli, Italy
| | - G La Verde
- University of Naples Federico II, Department of Physics "E. Pancini", Via Cinthia 21, 80126, Napoli, Italy
| | - Mohamed Y Hanfi
- Nuclear Materials Authority, El Maadi, Cairo, P.O. Box 530, Egypt; Institute of Physics and Technology, Ural Federal University, St. Mira, 19, 620002, Yekaterinburg, Russia.
| |
Collapse
|
3
|
La Verde G, D'Avino V, Sabbarese C, Roca V, Pugliese M. Radon surveys and effectiveness of remedial actions in spas on the Ischia island (Italy). Appl Radiat Isot 2022; 185:110221. [DOI: 10.1016/j.apradiso.2022.110221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2022] [Accepted: 03/31/2022] [Indexed: 11/02/2022]
|
4
|
Tribalto M, Papa G, Coppetelli U, Adorno G, Caravita T, Dentamaro T, Rainone A, Avvisati G, La Verde G, Leone G, Menichella G, Martelli M, Tabilio A, Iacone A, Fioritoni G, Majolino I, Scimè R, Mandelli F. Treatment of Multiple Myeloma with Autologous Blood Stem Cell Transplantation. Preliminary Results of an Italian Multicentric Pilot Study. Int J Artif Organs 2018. [DOI: 10.1177/039139889301605s10] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Starting from May, 1991, 35 untreated myeloma patients entered a multicentric pilot study to evaluate the feasibility of a program of PBSC transplantation for previously untreated myeloma patients. The schedule was as follows: 2 cycles of VAD followed by CY, 7 g/mq + G-CSF (Granulokine, Roche) for 14 days, to increase and collect PBSC. The subsequent conditioning regimen was Melphalan + Busulfan followed by G-CSF. As maintenance R alpha-2 IFN was given, until relapse. The median follow-up is 14 months (4-22). On April 1993, 34 patients received at least 2 cycles of VAD, 27 were submitted to PBSC collection, 22 received conditioning regimen plus PBSC and 16 of them are in the maintenance treatment with IFN. Considering 28 patients for an intention to treat evaluation (35 -7 in treatment), responding patients are 71% with 46% who achieved CR. White cells and platelets raised to > 1000/mmc and >50,000/mmc after a median period of 10 and 13 days, from CY, and 11 and 14 days from transplant, respectively. Two patients relapsed, 2 others died while in PR because of CMV epatitis and candida pneumonia. The median number of CD34+ cells and CFU-GM was 24.75 x 106/kg b.w. and 28.1 x 104/kg b.w. respectively. In conclusion this treatment seems to be feasible and with low toxicity, but a longer follow-up is needed to evaluate the progression free survival of the high proportion of responding patients that we observed.
Collapse
Affiliation(s)
- M. Tribalto
- Department of Hematology, “Tor Vergata” University, Roma
| | - G. Papa
- Department of Hematology, “Tor Vergata” University, Roma
| | - U. Coppetelli
- Department of Hematology, “Tor Vergata” University, Roma
| | - G. Adorno
- Department of Hematology, “Tor Vergata” University, Roma
| | - T. Caravita
- Department of Hematology, “Tor Vergata” University, Roma
| | - T. Dentamaro
- Department of Hematology, “Tor Vergata” University, Roma
| | - A. Rainone
- Department of Hematology, “Tor Vergata” University, Roma
| | - G. Avvisati
- Department of Hematology, “La Sapienza” University, Roma
| | - G. La Verde
- Department of Hematology, “La Sapienza” University, Roma
| | - G. Leone
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - G. Menichella
- Department of Hematology, “Sacro Cuore” Catholic University, Roma
| | - M. Martelli
- Division of Hematology, University of Perugia, Perugia
| | - A. Tabilio
- Division of Hematology, University of Perugia, Perugia
| | - A. Iacone
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - G. Fioritoni
- Department of Hematology and Transfusion, Pescara Civic Hospital, Pescara
| | - I. Majolino
- Division of Hematology, “V. Cervello” Hospital, Palermo, Italy
| | - R. Scimè
- Division of Hematology, “V. Cervello” Hospital, Palermo, Italy
| | - F. Mandelli
- Department of Hematology, “La Sapienza” University, Roma
| |
Collapse
|
5
|
Carlesimo M, Narcisi A, Orsini D, Abruzzese C, Di Russo P, La Verde G, Cox M. Eosinophilic Dermatosis Associated with Haematological Malignancies: A Report of Two Cases. EUR J INFLAMM 2017. [DOI: 10.1177/1721727x1201000212] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- M. Carlesimo
- U.O.C. Dermatology, II Unit University of Rome “Sapienza”, Rome, Italy
| | - A. Narcisi
- U.O.C. Dermatology, II Unit University of Rome “Sapienza”, Rome, Italy
| | - D. Orsini
- U.O.C. Dermatology, II Unit University of Rome “Sapienza”, Rome, Italy
| | - C. Abruzzese
- U.O.C. Dermatology, II Unit University of Rome “Sapienza”, Rome, Italy
| | - P.P. Di Russo
- U.O.C. Dermatology, II Unit University of Rome “Sapienza”, Rome, Italy
| | - G. La Verde
- U.O.C. Hematology, II Unit University of Rome “Sapienza ”, Rome, Italy
| | - M.C. Cox
- U.O.C. Hematology, II Unit University of Rome “Sapienza ”, Rome, Italy
| |
Collapse
|
6
|
Carlesimo M, Abruzzese C, Cortesi G, Ciccone A, Poggi C, Lombardi M, Moscetti A, La Verde G, Mari E. Pseudoxanthoma Elasticum and Light-Chain Amyloidosis. EUR J INFLAMM 2012. [DOI: 10.1177/1721727x1201000329] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Pseudoxanthoma elasticum is a heritable disorder of connective tissue characterized by cutaneous, vascular and ocular changes that result from the accumulation of fragmented elastic fibres. Even though the etiopathogenesis is not still completely understood, in recent years in literature some Authors have considered pseudoxanthoma elasticum as a metabolic disorder. We present the case of a 45-year-old man affected by pseudoxanthoma elasticum and light-chain amyloidosis and we discuss the possible reasons that led to this association.
Collapse
Affiliation(s)
- M. Carlesimo
- NESMOS, U.O.C. Dermatology, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - C. Abruzzese
- NESMOS, U.O.C. Dermatology, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - G. Cortesi
- NESMOS, U.O.C. Dermatology, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - A.M. Ciccone
- U.O.C. Thorax Surgery, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - C. Poggi
- U.O.C. Thorax Surgery, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - M. Lombardi
- U.O.C. Histopathology, Sant Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - A. Moscetti
- U.O.C. Ematology Sant Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psycology, Rome, Italy
| | - G. La Verde
- U.O.C. Ematology Sant Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psycology, Rome, Italy
| | - E. Mari
- U.O.C. Clinica Dermatologica Dipartimento di Medicina Interna e Specialita Mediche University of Rome “Sapienza”, Rome, Italy
| |
Collapse
|
7
|
Moscetti A, Saltarelli F, Bianchi MP, Monarca B, De Biase L, Porrini R, Antolino G, La Verde G. Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse. Amyloid 2011; 18 Suppl 1:152-4. [PMID: 21838469 DOI: 10.3109/13506129.2011.574354057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- A Moscetti
- AO Sant'Andrea, UOS Diagnosi e Cura delle Discrasie Plasmacellulari e delle Amiloidosi, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Petrucci MT, La Verde G, Ribersani M, Avvisati G, Mandelli F. Intravenous melphalan and dexamethasone followed by lymphoblastoid alpha interferon in higher risk multiple myeloma patients. Leuk Lymphoma 2000; 39:131-8. [PMID: 10975391 DOI: 10.3109/10428190009053546] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Intermittent courses of melphalan and prednisone is still the standard chemotherapy for the initial treatment of multiple myeloma (MM) in patients who cannot undergo high-dose chemotherapy/radiotherapy with either allogeneic or autologous stem cell transplantation. However, the absorption of the drug from the gastrointestinal tract is highly variable from patient to patient and therefore, different plasma levels of the drug are reached in the blood of individual MM patients. In order to overcome this limitation we decided to use intermediate dose (15-30 mg/m2, day 1) intravenous melphalan in resistant or relapsing MM patients as well as in untreated patients not eligible for a more aggressive protocol. Moreover, considering the good results obtained by other investigators using dexamethasone alone or associated with interferon in the treatment of resistant or relapsing MM patients, dexamethasone (40 mg total dose, day 1) and the lymphoblastoid alpha interferon (3 MU, 3 times a week x 3 weeks, from day 8 to day 26 of each course) were added to intravenous melphalan. Courses were repeated every 5 weeks for a total of 6 cycles. We treated 62 MM patients obtaining a response (defined as reduction > 25% of the initial monoclonal component value associated with disappearance of the clinical symptoms) in 38 out 62 evaluable patients (61%) and stable disease (defined as a decrease of < 25% in the base-line serum monoclonal component level with disappearance of all symptoms present at diagnosis) in 9 (14.5%) more patients. The overall median response duration was 14 months and the overall median survival duration (from the time of inclusion in this protocol) for the 62 patients entered into the study was 34 months. No severe (Grade 3-4 of the WHO) hematological as well as non hematological toxicities were observed. This lack of severe toxicity allowed us to administer the drugs on an outpatient basis. In conclusion, the overall response and the low grade of toxicity in this category of patients are encouraging and suggest that this protocol is both effective and safe treatment for high risk MM patients.
Collapse
Affiliation(s)
- M T Petrucci
- Dipartimento di Biotecnologie Cellulari ed Ematologia Università La Sapienza Roma, Italy.
| | | | | | | | | |
Collapse
|
9
|
Cauda R, Lucia MB, Marasca G, Rutella S, Petrucci MT, La Verde G, Gastaldi R. Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy. Eur J Haematol 1999; 63:134-5. [PMID: 10480293 DOI: 10.1111/j.1600-0609.1999.tb01127.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
La Verde G, Pulsoni A, Petrucci MT, Mandelli F. [Therapy of multiple myeloma]. Recenti Prog Med 1997; 88:186-93. [PMID: 9206817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The association of melphalan and prednisone, introduced in the sixties, allowed a dramatic improvement in the prognosis of multiple myeloma. The subsequent evaluation of different polychemotherapeutic schedules did not ameliorate the results with respect to the melphalan-prednisone association, which remains the treatment of choice in patients older than 60-65 years. In younger patients high dose therapy allowed, in the recent years, significant improvement in terms of reduction of tumor mass and survival. The use of interferon as maintenance treatment allowed a prolongation of the response phase obtained after induction treatment. In this paper we discuss current trends in the management of multiple myeloma and related complication.
Collapse
Affiliation(s)
- G La Verde
- Dipartimento di Biopatologia Umana, Università La Sapienza, Roma
| | | | | | | |
Collapse
|
11
|
Tribalto M, Papa G, Coppetelli U, Adorno G, Caravita T, Dentamaro T, Rainone A, Avvisati G, La Verde G, Leone G. Treatment of multiple myeloma with autologous blood stem cell transplantation. Preliminary results of an Italian multicentric pilot study. Int J Artif Organs 1993; 16 Suppl 5:51-6. [PMID: 7516917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Starting from May, 1991, 35 untreated myeloma patients entered a multicentric pilot study to evaluate the feasibility of a program of PBSC transplantation for previously untreated myeloma patients. The schedule was as follows: 2 cycles of VAD followed by CY, 7 g/mq+G-CSF (Granulokine, Roche) for 14 days, to increase and collect PBSC. The subsequent conditioning regimen was Melphalan+Busulfan followed by G-CSF. As maintenance R alpha-2 IFN was given, until relapse. The median follow-up is 14 months (4-22). On April 1993, 34 patients received at least 2 cycles of VAD, 27 were submitted to PBSC collection, 22 received conditioning regimen plus PBSC and 16 of them are in the maintenance treatment with IFN. Considering 28 patients for an intention to treat evaluation (35-7 in treatment), responding patients are 71% with 46% who achieved CR. White cells and platelets raised to > 1000/mmc and > 50,000/mmc after a median period of 10 and 13 days, from CY, and 11 and 14 days from transplant, respectively. Two patients relapsed, 2 others died while in PR because of CMV epatitis and candida pneumonia. The median number of CD34+ cells and CFU-GM was 24.75 x 10(6)/kg b.w. and 28.1 x 10(4)/kg b.w. respectively. In conclusion this treatment seems to be feasible and with low toxicity, but a longer follow-up is needed to evaluate the progression free survival of the high proportion of responding patients that we observed.
Collapse
Affiliation(s)
- M Tribalto
- Department of Hematology, Tor Vergata University, Roma, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Abstract
Although the association of bone marrow fibrosis with plasma cell dyscrasias has already been described in several reports, the close relationship between these entities still remains unclear. In this report we describe a patient with clinical and pathologic findings which initially suggested a diagnosis of myelofibrosis, subsequently shown to be coexistent with multiple myeloma. Possible explanations for this association are discussed.
Collapse
Affiliation(s)
- A Pulsoni
- Department of Human Biopathology, University La Sapienza, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
13
|
Coppetelli U, Avvisati G, Tribalto M, Cantonetti M, La Verde G, Petrucci T, Stasi R, Papa G. [Recent biological and therapeutic advances in multiple myeloma]. Recenti Prog Med 1992; 83:520-7. [PMID: 1439122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Multiple myeloma still remains a fatal disease. However, in the last months new biological and clinical informations have been provided about this disease. In particular, the immunophenotype of myeloma cells seems indicate, in some patients, a clonal involvement of a stem cell in the pathogenesis of mieloma. Moreover, new biological insights concerning the cytokine network, have revealed a probable effect of some cytokines, such as IL6, IL3, IL4. Finally, new insights in the biology of multiple myeloma have been provided by studies of molecular biology and flow cytometry. As for therapy, the best conventional induction treatment still remains to be defined. In the last years, the increased use of alpha Interferon and new therapeutic modalities, such as transplantation procedures in multiple myeloma, open new hopes toward a cure of this disease. Therefore, in the future a better knowledge of the multiple myeloma biology, associated with a wider use of new effective therapeutic approaches will certainly improve the natural course of this disease.
Collapse
Affiliation(s)
- U Coppetelli
- Cattedra di Ematologia, Università Tor Vergata, Roma
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Chistolini A, Dragoni F, Ferrari A, La Verde G, Arcieri R, Ege Mohamud A, Mazzucconi MG. Intranasal DDAVP: biological and clinical evaluation in mild factor VIII deficiency. Haemostasis 1991; 21:273-7. [PMID: 1806455 DOI: 10.1159/000216236] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
We report a study undertaken to test the biological effect of intranasal 1-deamino-8-D-arginine vasopressin (DDAVP) and its efficacy in the treatment of bleedings in patients with mild factor VIII deficiency. The biological study was carried out in 20 patients: an increase of factor VIII:C and von Willebrand factor antigen levels was observed after inhalation of DDAVP at average post/pre inhalation ratios of 2.80 and 1.72, respectively. No relevant alterations of fibrinolysis were noted. In fact, we only observed a simultaneous increase of tissue plasminogen activator and plasminogen activator inhibitor, without modification of D-dimer. In 10 cases intranasal DDAVP has been used in the prevention or in the treatment of bleeding complications: no bleedings were observed.
Collapse
Affiliation(s)
- A Chistolini
- Section of Haematology, Department of Human Biopathology, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
15
|
Chistolini A, Papacchini M, Mazzucconi MG, La Verde G, Arcieri R, Ferrari A, Paesano R, Pachi A, Mariani G. Carrier detection and prenatal diagnosis in haemophilia A and B. Haematologica 1990; 75:424-8. [PMID: 1982946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Sixty probable carriers of haemophilia from 25 families were studied by using coagulation phenotype and DNA analysis: 33 with haemophilia A and 27 with haemophilia B. Coagulation phenotype was based on factor VIII/IX assay and DNA analysis on the examination of restriction fragment length polymorphisms (RFLPs) within and closely linked to factor VIII or IX: 3 RFLP for factor VIII and 3 for factor IX. The comparison between the coagulation phenotype and RFLP analysis showed the misclassification of 15 females (6 for haemophilia A and 9 for haemophilia B). Four prenatal haemophilia A diagnosis were made by DNA analysis of chorionic villi, taken with a transcervical trophoblastic biopsy, between the 18th and the 11th week.
Collapse
Affiliation(s)
- A Chistolini
- Istituto di Biopatologia Umana, Università La Sapienza, Roma, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Chistolini A, Mazzucconi MG, Tirindelli MC, La Verde G, Ferrari A, Mandelli F. Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates. Acta Haematol 1990; 83:163-5. [PMID: 2109459 DOI: 10.1159/000205197] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
A case of disseminated intravascular coagulation (DIC) and fatal myocardial infarction in a haemophilia B patient is described. DIC occurred after 4 days of therapy with unactivated prothrombin complex concentrates during the post-operative period. Therapy with fresh frozen plasma, heparin and antithrombin III concentrates was started without efficacy; after autopsy myocardial infarction was evident.
Collapse
Affiliation(s)
- A Chistolini
- Department of Human Biopathology, University La Sapienza, Rome, Italy
| | | | | | | | | | | |
Collapse
|